Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)

Published:2019-05-22 Issue:3 Volume:143 Page:573-581
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Jaeckle Kurt A.^ORCID,Anderson S. K.,Twohy Erin L.,Dixon Jesse G.,Giannini Caterina,Jenkins Robert,Egorin Merrill J.,Sarkaria Jann N.,Brown Paul D.,Flynn P. J.,Schwerkoske John,Buckner Jan C.,Galanis Evanthia

Funder

National Institutes of Health (US)- Alliance Chairman's Grant

National Institutes of Health (US)-Alliance Statistics and Data Center Grant

National Institutes of Health (US)- Alliance NCORP Grant

National Institutes of Health (US) Alliance NCTN Biorepository and Biospecimen Resource Grant

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-019-03194-z.pdf

Reference28 articles.

1. Smith JS, Wang XY, Qian J, Hosek SM, Scheithauer BW, Jenkins RB, James CD (2000) Amplification of the platelet-derived growth factor receptor -A (PDGFRA) gene occurs in oligodendrogliomas with Grade IV anaplastic features. J Neuropathol Exp Neurol 59:495–503

2. DiRocco F, Carroll RS, Zhang J, Black PM (1998) Platelet-derived growth factor and its receptor expression in human oligodendrogliomas. Neurosurgery 42:341–346

3. Ranza E, Mazzini G, Facoetti A, Nano R (2010) In-vitro effects of the tyrosine kinase inhibitor imatinib on glioblastoma cell proliferation. J Neurooncol 96:349–357

4. Fleming TR (1982) One-sample multiple testing procedure for phase II clinical trials. Biometrics 38:143–151

5. Duffy D, Santner T (1987) Confidence intervals for a binomial parameter based on multistage tests. Biometrics 43:81–93

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. REVOLUMAB: A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomas;European Journal of Cancer;2024-05

2. Olaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA Network;Neuro-Oncology Advances;2024-01-01

3. Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017;Cancer;2023-11-02

4. The role of angiogenic growth factors in the immune microenvironment of glioma;Frontiers in Oncology;2023-09-13

5. Osteomalacia in Adults: A Practical Insight for Clinicians;Journal of Clinical Medicine;2023-04-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3